Stock Pick

  • 3 five-star ASX 200 shares to buy in June

    asx shares to buy

    If you’re looking for additions to your portfolio in June, then I think the three ASX 200 shares listed below would be great options.

    I believe these shares are some of the best the ASX has to offer and could generate market-beating returns for investors in the future.

    Here’s why I rate them as five-star stocks:

    Appen Ltd (ASX: APX)

    The first five-star stock I would consider buying is Appen. Through its million-plus team of crowd-sourced experts, Appen prepares the data that goes into the artificial intelligence (AI) and machine learning models of some of the biggest tech companies in the world. This includes the likes of Facebook, Microsoft, and Apple. In respect to the latter, Appen helped the tech giant develop its intelligent assistant, Siri. Given how important AI is becoming, I expect demand for its services to continue to grow over the next decade. This should underpin strong earnings growth for many years to come.

    Nanosonics Ltd (ASX: NAN)

    Nanosonics is another ASX 200 share that I would give five-stars. The infection control specialist has been growing at a very strong rate over the last few years thanks to the growing installed base of its trophon EPR disinfection system for ultrasound probes. The beauty of this product is that as its installed base grows, so too does the recurring revenue from the consumables it requires. While this product alone could drive strong earnings growth for the next decade thanks to its massive market opportunity, there will soon be more products in its portfolio. Nanosonics is planning to launch several new secretive products targeting unmet needs in the coming years.

    REA Group Limited (ASX: REA)

    A final five-star stock to consider buying is REA Group. It is a digital advertising company that operates Australia’s leading property websites. It also operates real estate websites in Europe, Asia, and the United States. While market conditions are tough at the moment, I expect the tide to turn once the crisis passes. When it does, I expect the realestate.com.au operator’s earnings growth to accelerate and drive its shares higher. All in all, I think REA Group is one of the best buy and hold options on the ASX.

    And here are more top shares to consider. All five recommendations below look dirt cheap after the crash…

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!….

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off its high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nanosonics Limited. The Motley Fool Australia owns shares of Appen Ltd. The Motley Fool Australia has recommended Nanosonics Limited and REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 five-star ASX 200 shares to buy in June appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2MftRTC

  • Got $50,000 to invest for income? Pick these 5 ASX dividend shares

    ASX dividend shares

    The idea of investing $50,000 for income is an important task that should be carefully thought out. You can’t just pick any ASX dividend share.

    Just look at what has happened to the dividends of National Australia Bank Ltd (ASX: NAB) and Telstra Corporation Ltd (ASX: TLS). Big cuts over the past few years.

    I’d only want to choose the best ASX dividend shares with rock solid income prospects:

    Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) 

    Soul Patts is my favourite ASX dividend share. It has increased its dividend every year since 2000. It’s a unique income share when it comes to investing on the ASX. It has actually paid a dividend every year in its listed life going back to 1903.

    It’s invested across a broad range of industries including telecommunications, pharmacies, building products and agriculture. It has already forecast an increased dividend in six months, which should bring some comfort to those who rely on dividends.

    It pays the dividend out of the investment income it receives, less operating expenses, so the dividend is well funded. Some of the net cashflow is kept back to re-invest for more growth. It offers a grossed-up dividend yield of 4.5%.

    WAM Microcap Limited (ASX: WMI)

    It’s important to recognise that there are top ASX dividend shares outside of the ASX 20. Listed investment companies (LICs) have the ability to generate profits from capital gains made and then pay out a smoothed dividend for shareholders.

    WAM Microcap invests in small shares with market capitalisations under $300 million. This hunting ground is where you can find some of the best opportunities. But you don’t need to do the work to find those ideas, you can leave it to the WAM investment team.

    The LIC has been steadily growing its dividend since inception a few years ago. It currently offers a forward grossed-up dividend yield of 6.9%.

    Brickworks Limited (ASX: BKW)

    Brickworks is a diversified property business. I think it’s another of the best ASX dividend shares out there because it hasn’t decreased its dividend in over 40 years.

    It has a high-quality group of building products businesses that supplies bricks, paving, masonry, precast, roofing and so on across Australia. It also owns a few brickmakers in the US after acquiring them recently. Long-term construction should remain a feature in the coming years.

    But it’s okay that the coronavirus is causing disruption to construction right now. It can fund its reliable dividend from cashflow from the defensive industrial property trust it’s a part-owner of, as well as from its large shareholding in Soul Patts.

    Brickworks currently offers a grossed-up dividend yield of 5.4%.

    Rural Funds Group (ASX: RFF)

    I think Rural Funds is quality ASX dividend share because of its consistent distribution growth. Management aim to increase the distribution by 4% every year.

    The agricultural real estate investment trust (REIT) achieves this regular growth through contracted rental indexation and regular investing at its farms for productivity improvements for the tenant. This strategy is working particularly well with cattle farms right now.

    It’s invested across a diverse array of farms including almonds, cotton, macadamias, vineyards and cattle.

    It has already forecast a distribution of 11.28 cents for FY21, equating to a forward yield of 5.6%.

    Future Generation Investment Company Ltd (ASX: FGX)

    There are two big reasons to like Future Generation as an ASX dividend share.

    The first is for its attractive grossed-up dividend yield of 7.4%. Paying a solid (and growing) dividend is one of the main aims of Future Generation. It has been steadily increasing the dividend over the past few years.

    But the LIC doesn’t charge any management fees. Neither do the investment managers that Future Generation is invested in. Instead, it donates 1% of net assets each year to youth charities. I think that’s a great initiative to be a part of.

    Foolish takeaway

    If you don’t want to be buying or selling shares then I think the above five ASX dividend shares are great options. I’d happily invest $10,000 into each of them for long-term income. Hopefully all of them will grow (or at least maintain) the dividend during this difficult period.

    These aren’t the only five great dividend share options on the ASX. I’d also definitely want to look at this top dividend pick…

    NEW: Expert names top dividend stock for 2020 (free report)

    When our resident dividend expert Edward Vesely has a stock tip, it can pay to listen. After all, he’s the investing genius that runs Motley Fool Dividend Investor, the newsletter service that has picked huge winners like Dicker Data (+92%), SDI Limited (+53%) and National Storage (+35%).*

    Edward has just named what he believes is the number one ASX dividend stock to buy for 2020.

    This fully franked “under the radar” company is currently trading more than 24% below its all-time high and paying a 6.7% grossed-up dividend.

    The name of this dividend dynamo and the full investment case is revealed in this brand new free report.

    But you will have to hurry — history has shown it can pay dividends to get in early to some of Edward’s stock picks, and this dividend stock is already on the move.

    See the top dividend stock for 2020

    More reading

    Motley Fool contributor Tristan Harrison owns shares of FUTURE GEN FPO, RURALFUNDS STAPLED, WAM MICRO FPO, and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia owns shares of and has recommended Brickworks, RURALFUNDS STAPLED, Telstra Limited, and Washington H. Soul Pattinson and Company Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Got $50,000 to invest for income? Pick these 5 ASX dividend shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/36Lh44M

  • The Week In Cannabis: A Mixed Bag Leads Marijuana Stocks To Underperform

    The Week In Cannabis: A Mixed Bag Leads Marijuana Stocks To UnderperformThis week brought a mixed bag of news for the cannabis industry.Aphria Inc (NYSE: APHA) announced it will transfer its stock from the New York Stock Exchange to the Nasdaq exchange after the market close June 5, and a long list of earnings reports, some better than others.Cresco Labs Inc. (CSE: CL) (OTC: CRLBF) had a great week with numerous store-opening announcements. The company also reported first-quarter revenue of $66.4 million, up 60% from the previous quarter. "In Q1 we built, staffed, integrated, and refined our operations in the largest and most important cannabis markets in the U.S.," said the company's co-founder and CEO Charles Bachtell.TerrAscend Corp. (CSE: TER) (OTC: TRSSF) reported net sales of CA$34.8 million (US$25.2 million) for the first quarter of 2020, up 34% quarter-over-quarter and 139% year-over-year. The Toronto-based company reached a positive adjusted EBITDA of CA$4.9 million versus a loss of CA$5.5 million in the corresponding quarter last year.Amid restructuring efforts, Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) reported a fourth-quarter net loss of CA$1.3 billion ($946.4 million), up from the loss of CA$347.5 million it posted for the same quarter a year ago. On the other hand, net revenue of CA$399 million was up 76% year-over-year, but down 13% quarter-over-quarter. See the full results here.Following the report, Eric Choe, founder of StockDweebs, said Canopy Growth is well-positioned to rally on the production, distribution and sale of its cannabis products despite the recent downfall: "It relies primarily on retail traffic and the sale of medicinal and recreational cannabis products – this could boost overall sales and top-line figures once stores start opening post-COVID."Cantor Fitzgerald's Pablo Zuanic seemed to disagree, noting the company has considerable downside risk following the fourth-quarter report.See more financial results from Vibe Bioscience Ltd. (CSE: VIBE) (OTC: VBSCF), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), Slang Worldwide (CNSX: SLNG), Evogene Ltd. (NASDAQ: EVGN), and more, at our Cannabis Earnings Center.Don't miss this opportunity to connect with THE cannabis movers and shakers from across the globe during Benzinga's first Virtual Cannabis Capital Conference on June 1.For their part, ETFs closed the week on the red. Over the five trading days of the week: * ETFMG Alternative Harvest ETF (NYSE: MJ) lost 2%. * AdvisorShares Pure Cannabis ETF (NYSE: YOLO) slipped 0.37%. * Cannabis ETF (NYSE: THCX) dropped 3.85%. * Amplify Seymour Cannabis ETF (NYSE: CNBS) shed 2.83% of its value. * SPDR S&P 500 ETF Trust (NYSE: SPY) closed the period up 2.95%.Debra Borchardt, CEO of Green Market Report called the earnings results "staggering," adding "It seems like it will be a long time before these companies can recover from past management decisions and give investors a company that they can believe in."In other news, real estate investment trust Innovative Industrials Properties (NYSE: IIPR) reported the upsize and pricing of an underwritten public offering of its common shares at an estimated cost of $100 million. The offering consists of 1,348,389 common shares.Banking and payment technology company Hypur partnered with business software provider Odoo to streamline the cannabis purchasing process. Together they will provide modern, digital payments, and bolster point-of-sale operations. The partnership will also enable customers utilize Hypur's new nationwide "safe checkout" feature, which was recently rolled out with Caliva, as well as online cannabis marketplace, Dutchie.Psychedelics company Red Light Holland Corp. started trading on the Canadian Securities Exchange under the ticker symbol "TRIP," and appointed Bruce Linton, the co-founder and former CEO of Canopy Growth, as chairman of its advisory board.Advanced Flower Capital Management LLC confirmed its associate has provided Nature's Medicines with $42 million in financing.Louisiana is moving forward with a piece of legislation that would make medical marijuana move easily available in the state by authorizing recommendations from any state-licensed physician, while updating the list of qualifiable medical conditions.House Bill 819 passed Senate vote on Wednesday by 28 to 6.Find our cannabis, hemp and psychedelics news in Spanish on El Planteo.More News From The Week True Terpenes, a producer of GMP/ISO/FSSC-certified terpenes, formed a scientific advisory board (SAB) to advance research in the cannabis industry. The SAB will be focused on studying the entourage effect, where the benefits of medical cannabis can be enhanced when combined with terpenes. Board members include Dr. Ethan Russo, a cannabis and pharmaceutical scientist who specializes in the entourage effect. Dr. Russo previously worked with GW Pharmaceuticals on progressing Epidiolex and Sativex through clinical trials, becoming the first cannabis-based drug to be approved by the Food & Drug Administration."There is a growing body of anecdotal evidence that supports the existence of the entourage effect. The profound potential for cannabis medicine to positively impact human health compels the cannabis industry to establish scientific proof of the synergistic interaction between terpenes and cannabinoids. True Terpenes has unmatched access to the global terpenes supply chain and a proprietary library of terpene profiles that our company is contributing to these efforts," said CEO Chris Campagna.New Wave Holdings Corp. (CSE: SPOR) (OTC: TRMND) announced its plans to sponsor TheraPsil, a Victoria, British Columbia-based non-profit coalition seeking legal access to psilocybin for Canadians in palliative care. The coalition is focused on providing legal, safe access to psychedelic therapies as well as education. In collaboration with domestic and global partners, the organization plans to help support the development of effective protocols in collaboration with health professionals."We are looking forward to working with TheraPsil to help bring psychedelic therapy to patients in palliative care. It is through education, training, research and the championing of those patients who could benefit from access to these therapies that we will see this initiative move forward and see so many people be helped," said Trumbull Fisher, President of New Wave. Medical Marijuana, Inc. (OTC: MJNA) subsidiary Kannaway welcomed Earl Monroe, former NBA player for the Baltimore Bullets and the New York Knicks, to its Sports Team to help spread awareness on the benefits of CBD for athletes. Monroe played 13 seasons in the NBA. He was inducted into the Naismith Memorial Basketball Hall of Fame in 1990. "Earl uses our Premium Full Spectrum CBD and topical salve products to help manage the aches that are a result of many years of championing a professional sport," said Kannaway® CEO Blake Schroeder. "We could not be more proud that our products have made a positive difference for him,"A class-action lawsuit claiming Colorado-based Elixinol, LLC's CBD products were illegal to sell under federal regulations was dismissed. The company creates, manufactures and sells various CBD products, including capsules, tinctures and dog treats. In McCarthy v Elixinol, LLC, lawyers argued that under the 2018 Farm Bill the hemp-derived CBD company had the right to transport and ship hemp. In addition, the FDA's current regulations do not prohibit any company from selling hemp-based products. The suit was filed in the United States District Court for the Northern District of California in December 2019."Elixinol isn't the only hemp and CBD company facing these unfounded class action lawsuits," says Jonathan Miller, chair of Frost Brown Todd's hemp industry team and general counsel of the U.S. Hemp Roundtable. "These attorneys previously earned a similar dismissal in Fausett, et al. v. Koi CBD, LLC and are working other pending cases claiming product impurities and failed drug tests. The 2018 Farm Bill made hemp legal and companies running legitimate businesses that are building this new industry should be welcomed and embraced."Top Stories Of The Week Check out the top stories on Benzinga Cannabis this week: * A Medicinal Cannabis Company That's Conducting Clinical Research On Autism, Insomnia, And More * Poison Pills: A Common Component In Lawmaking, M&A And Now Cannabis * A Snapshot of America's Medical Marijuana Marketplaces: Michigan * Cannabis Strain Names Are Meaningless: What Is The Industry Doing About It? * Virtual Benzinga Cannabis Capital Conference Offers Sneak Peek At Pot Industry's Coronavirus Recovery * MindMed To Include MDMA to Research Portfolio * Benzinga Cannabis Capital Conference Presents: Vivien Azer, Star Marijuana Analyst * Benzinga Cannabis Capital Conference Presents: Isiah Thomas, NBA Legend And CBD Investor * Benzinga Cannabis Capital Conference Presents: From Bud to Bloom – Grow Your Business The Right Way * What Isiah Thomas, John Salley And Al Harrington Have In Common (Hint: It's Not Basketball)Check out these and many other cannabis stories on Benzinga.com/cannabisLead image by Ilona Szentivanyi. Copyright: Benzinga.See more from Benzinga * ESPAÑOL • Odoo Ingresa a la Industria del Cannabis, Isiah Thomas, Avicanna en Colombia, Aphria, Aurora, y Más * The Week In Cannabis: A Great Week For Stocks Driven By Confusion, Aurora's Rally, New Advisors To Benzinga * ESPAÑOL • Reportes Trimestrales, Coronavirus y Acciones de Cannabis en Subida: ¿Qué Está Pasando?(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/3eyH71L

The Latest